Literature DB >> 22544194

Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe.

J Dzangare1, E Gonese, O Mugurungi, T Shamu, T Apollo, D E Bennett, K F Kelley, M R Jordan, C Chakanyuka, F Cham, R M Banda.   

Abstract

Monitoring human immunodeficiency virus drug resistance (HIVDR) early warning indicators (EWIs) can help national antiretroviral treatment (ART) programs to identify clinic factors associated with HIVDR emergence and provide evidence to support national program and clinic-level adjustments, if necessary. World Health Organization-recommended HIVDR EWIs were monitored in Zimbabwe using routinely available data at selected ART clinics between 2007 and 2009. As Zimbabwe's national ART coverage increases, improved ART information systems are required to strengthen routine national ART monitoring and evaluation and facilitate scale-up of HIVDR EWI monitoring. Attention should be paid to minimizing loss to follow-up, supporting adherence, and ensuring clinic-level drug supply continuity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22544194      PMCID: PMC3338304          DOI: 10.1093/cid/cir1014

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

1.  Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: a 5-year cohort study.

Authors:  Gregory M Lucas; Richard E Chaisson; Richard D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2003-07-01       Impact factor: 3.731

2.  The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.

Authors:  Diane E Bennett; Silvia Bertagnolio; Donald Sutherland; Charles F Gilks
Journal:  Antivir Ther       Date:  2008

3.  Assessments of HIV drug resistance mutations in resource-limited settings.

Authors:  Michael R Jordan
Journal:  Clin Infect Dis       Date:  2011-04-15       Impact factor: 9.079

4.  Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy.

Authors:  M Maskew; P MacPhail; C Menezes; D Rubel
Journal:  S Afr Med J       Date:  2007-09

5.  Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa.

Authors:  Ziad El-Khatib; David Katzenstein; Gaetano Marrone; Fatima Laher; Lerato Mohapi; Max Petzold; Lynn Morris; Anna Mia Ekström
Journal:  PLoS One       Date:  2011-03-09       Impact factor: 3.240

  5 in total
  9 in total

1.  Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011.

Authors:  M R Jordan; D E Bennett; M A Wainberg; D Havlir; S Hammer; C Yang; L Morris; M Peeters; A M Wensing; N Parkin; J B Nachega; A Phillips; A De Luca; E Geng; A Calmy; E Raizes; P Sandstrom; C P Archibald; J Perriëns; C M McClure; S Y Hong; J H McMahon; N Dedes; D Sutherland; S Bertagnolio
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

2.  Treating our way out of AIDS?

Authors:  Mary T Bassett; Karen Brudney
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

3.  Use of amplification refractory mutation system PCR assay as a simple and effective tool to detect HIV-1 drug resistance mutations.

Authors:  Aubin J Nanfack; Lucy Agyingi; Jean Jacques N Noubiap; Johnson N Ngai; Vittorio Colizzi; Phillipe N Nyambi
Journal:  J Clin Microbiol       Date:  2015-03-18       Impact factor: 5.948

4.  Early warning indicators for first-line virologic failure independent of adherence measures in a South African urban clinic.

Authors:  Vincent C Marconi; Baohua Wu; Jane Hampton; Claudia E Ordóñez; Brent A Johnson; Dinesh Singh; Sally John; Michelle Gordon; Anna Hare; Richard Murphy; Jean Nachega; Daniel R Kuritzkes; Carlos del Rio; Henry Sunpath
Journal:  AIDS Patient Care STDS       Date:  2013-12       Impact factor: 5.078

5.  Use of Proviral DNA to Investigate Virus Resistance Mutations in HIV-infected Zimbabweans.

Authors:  Tutsirai V Musingwini; Danai T Zhou; Doreen Mhandire; Kerina Duri; Exnevia Gomo; Olav Oktedalen; Benjamin Chimukangara; Tinei Shamu; Sandra Shawarira-Bote; Collet Dandara; Babill Stray-Pedersen
Journal:  Open Microbiol J       Date:  2017-04-28

6.  HIV drug resistance early warning indicators in Namibia for public health action.

Authors:  Anna Jonas; Justice Gweshe; Milner Siboleka; Michael Deklerk; Michael Gawanab; Alfons Badi; Victor Sumbi; Dawn Pereko; Abraham Blom; Samson Mwinga; Michael R Jordan; Logan Jerger; Kiger Lau; Steven Y Hong
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

7.  Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.

Authors:  Joseph Fokam; Serge C Billong; Anne C Z K Bissek; Etienne Kembou; Pascal Milenge; Ibile Abessouguie; Armand S Nkwescheu; Zephirin Tsomo; Avelin F Aghokeng; Grace D Ngute; Peter M Ndumbe; Vittorio Colizzi; Jean B N Elat
Journal:  BMC Public Health       Date:  2013-04-08       Impact factor: 3.295

8.  HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance.

Authors:  Anna Jonas; Victor Sumbi; Samson Mwinga; Michael DeKlerk; Francina Tjituka; Scott Penney; Michael R Jordan; Tiruneh Desta; Alice M Tang; Steven Y Hong
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

9.  Population-based monitoring of HIV drug resistance early warning indicators in Uganda: A nationally representative survey following revised WHO recommendations.

Authors:  Juliet Asio; Christine Watera; Norah Namuwenge; Wilford Kirungi; Joshua Musinguzi; Kaggwa Mugagga; Ronald Busobozi; Bridget Jolly Tusiime; Tom Lutalo; Edward Katongole Mbidde; Pontiano Kaleebu
Journal:  PLoS One       Date:  2020-04-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.